- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02224638
Wound Management for Sacral Pressure Ulcers With Necrotic Tissue
July 15, 2019 updated by: Medline Industries
Evaluation of Wound Management for Sacral Pressure Ulcers With Necrotic Tissue
Evaluation of a wound care debridement product and a moisturizer on sacral pressure ulcer wounds
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Pressure ulcers on the sacral area will be applied with either a wound debridement product or a wound moisturizer product plus a gentle wound dressing to manage wound closure over a 2-3 week period of treatment.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 606025
- Swedish Covenant Hospital
-
Chicago, Illinois, United States, 60625
- Harmony Residential Facility
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female subjects of any age
- Sacral wounds with necrotic tissue
Exclusion Criteria:
- 3rd degree burns
- know hypersensitivity to products
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: TheraHoney HD
Honey product
|
Honey
|
ACTIVE_COMPARATOR: SkinTegrity
Skin moisturizer
|
Hydrogel
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Wounds Healed
Time Frame: 3 weeks
|
Percentage of wounds that were complete or partially healed with either treatment measured by change in wound size of sacral pressure ulcer
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Adverse Events
Time Frame: 3 weeks
|
Adverse events related to the presence or absence of wound infections and worsening in ulcer staging.
|
3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nancy Chaiken, RN, Swedish Covenant Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (ACTUAL)
August 1, 2015
Study Completion (ACTUAL)
August 1, 2015
Study Registration Dates
First Submitted
August 20, 2014
First Submitted That Met QC Criteria
August 21, 2014
First Posted (ESTIMATE)
August 25, 2014
Study Record Updates
Last Update Posted (ACTUAL)
July 24, 2019
Last Update Submitted That Met QC Criteria
July 15, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R14-028
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcers
-
KLOX Technologies Inc.CompletedPressure Ulcers Stage II | Pressure Ulcers Stage IIICanada
-
EmoledRecruitingPressure Ulcer | Pressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure SoreItaly
-
ULURU Inc.United States Department of DefenseRecruitingPressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Signorini Medicale S.r.l.Opera CRO, a TIGERMED Group CompanyNot yet recruitingBurn Wound | Pressure Ulcers Stage II | Pressure Ulcers Stage IIIRomania
-
Bruin Biometrics, LLCCompleted
-
Charite University, Berlin, GermanyCompleted
-
Central Arkansas Veterans Healthcare SystemAbbottTerminatedPressure UlcersUnited States
-
Leaf Healthcare, Inc.Centauri Medical, Inc.Completed
-
Hill-RomCompletedPressure UlcersUnited States
Clinical Trials on TheraHoney HD
-
University of CalgaryCompletedInflammatory Bowel DiseaseCanada
-
The University of QueenslandCanadian Institutes of Health Research (CIHR); Queensland Health; Medical Research...RecruitingKidney FailureAustralia, Canada
-
Ariel UniversityTel Aviv UniversityCompleted
-
The University of Texas at DallasCompleted
-
Shanghai Mental Health CenterChinese Academy of SciencesTerminated
-
NYU Langone HealthBoston Children's HospitalCompleted
-
University of MichiganNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Dementia of Alzheimer TypeUnited States
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)Active, not recruitingMajor Depressive DisorderUnited States
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedEnd Stage Renal DiseaseUnited States
-
Lenstec IncorporatedCompleted